Medical
Teleflex Names Powell As Its New CFO
March 12, 2012 9:44 am | News | CommentsMedical equipment maker Teleflex Inc. said Monday that it has named Thomas Powell as chief financial officer, succeeding Richard Meier.
Boston Scientific Buys Heart Device Firm For $150M
March 9, 2012 9:03 am | News | CommentsMedical device maker said it will pay at least $150 million to acquire Cameron Health Inc., maker of a minimally-invasive heart defibrillator.
FDA Weighs Over-The-Counter Switch For Key Drugs
March 8, 2012 9:32 am | by Matthew Perrone, AP Health Writer | News | CommentsDriving the move is a wave of computer technology, including touch-screen kiosks found in pharmacies, designed to help patients self-diagnose common diseases.
Consumer Group Sues 8 Drugmakers Over Drug Coupons
March 7, 2012 2:28 pm | by Linda A. Johnson, AP Business Writer | News | CommentsCommunity Catalyst alleges increasingly common couponing programs appear to save patients money but violate federal bribery laws.
FDA Chemist Gets 5 Years For Insider Trading
March 6, 2012 3:05 pm | News | CommentsCheng Yi Liang pleaded guilty to using a confidential drug database to buy stock in various companies, which earned him nearly $3.8 million.
Merck: FDA Won't OK Combo Cholesterol Drug Yet
March 5, 2012 3:17 pm | by Linda A. Johnson, AP Business Writer | News | CommentsThe FDA is requiring additional study data on the compound, which combines Lipitor, the top-selling drug of all time, with Merck's cholesterol medicine Zetia.
Company Sued Over Bone Cement Surgery Deaths
March 5, 2012 9:11 am | News | CommentsMedical firm and former execs convicted of running unauthorized clinical tests of bone cement are blamed for contributing to the deaths of two elderly women.
Taiwan Biotech Sector Has New Rival: Samsung
March 2, 2012 9:21 am | News | CommentsThe South Korean electronics giant is branching out and is developing new drugs in cooperation with two American biotech firms.
Fake Avastin Contained Several Chemicals, No Drug
February 28, 2012 2:34 pm | by Matthew Perrone, AP Health Writer | News | CommentsCounterfeit versions of the popular cancer drug Avastin are completely ineffective, but would not likely have a dramatic effect on survival odds.
Bayer Earnings Hit By High-Tech Materials Division
February 28, 2012 9:34 am | News | CommentsThe company says its earnings picture was "mixed," and gave a cautious outlook for 2012 given "an economic situation marked by uncertainty."
Glenmark Generics Recalling Birth Control Pills
February 24, 2012 2:41 pm | News | CommentsBlisters of pills, made by the Indian company, were rotated so they were not in the proper sequence, which could make them ineffective.
A Safe Miracle Diet Drug Remains Elusive
February 24, 2012 1:19 pm | by Matthew Perrone, AP Health Writer | News | CommentsFor nearly a century, scientists have struggled to make a diet pill that helps people lose weight without side effects, like heart palpitations and birth defects.
Procter & Gamble To Cut 5,700 Jobs
February 23, 2012 2:13 pm | News | CommentsThe consumer products maker said the global cuts are part of a restructuring plan to save $10 billion by the end of the fiscal year ending in June 2016.
FDA Panel Backs Previously Rejected Obesity Pill
February 23, 2012 9:27 am | by Matthew Perrone, AP Health Writer | News | CommentsExperts agree new weight loss drugs are needed to treat an estimated 75 million obese adults in the U.S., but the FDA had thought some were not safe enough.
FDA: New Suppliers Ease Cancer Drug Shortages
February 21, 2012 1:01 pm | by Linda A. Johnson, AP Business Writer | News | CommentsRegulators said they've approved new suppliers for two crucial cancer drugs, but there are currently 283 other separate drugs in short supply.
J&J Recalls Infant Tylenol Over Bottle Confusion
February 17, 2012 10:56 am | by Linda A. Johnson, AP Business Writer | News | CommentsThe new infant bottle comes with a plastic syringe that's to be inserted into a flow restrictor for the correct dosage, but the restrictor often falls into the bottle.
FDA Raises Safety Concerns For Vivus Diet Pill
February 17, 2012 9:22 am | News | CommentsThe FDA had previously rejected the pill for potential heart problems and birth defects in women who become pregnant while taking the drug.
Counterfeit Drugs Becoming Big Business Worldwide
February 16, 2012 9:20 am | by Matthew Perrone, AP Health Writer | News | CommentsThe multibillion-dollar trade has largely been relegated to poor countries with lax regulations, but officials worry more counterfeits will be smuggled into America.
J&J: On Your Face, Not In It
February 15, 2012 12:21 pm | by Joel Hans, Managing Editor, Manufacturing.net | Blogs | CommentsJohnson and Johnson is becoming notorious for a long string of recalls and poor production practices, which leaves me wondering: How have they managed to avoid any genuine outcry?
Doctors Urge More Production Of Scarce Cancer Drug
February 14, 2012 9:29 am | by Linda A. Johnson, AP Business Writer | News | CommentsDoctors are panicking because methotexate is the key treatment for a common childhood cancer called acute lymphoblastic leukemia, and can cure 90 percent of cases.
FDA Shuts Down NJ Dental Products Company
February 13, 2012 1:43 pm | News | CommentsFederal health officials say Accurate Set has been legally barred from making and selling a variety of dental products due to violations at its manufacturing facility.
India's Global Pharmacy Role Threatened By EU Pact
February 10, 2012 9:33 am | by Katy Daigle, Associated Press | News | CommentsHealth industry workers worry India may bow to EU demands for strict IP protections, which would close down the supply of medicines to the world's poorest.
Funding Medical Device Innovation
February 8, 2012 9:24 am | by Rahul Sathe, Principal Mechanical Engineer, Surgical and Interventional Products, Cambridge Consultants | Articles | CommentsThe recent decline of venture financing is threatening innovation in the $300 billion global market for medical devices.
MRPC Expands Capabilities With New Class 100,000 Cleanroom
February 7, 2012 11:19 am | News | CommentsWisconsin-based MRPC, a single-source provider of medical device components and assemblies, has completed construction of a new cleanroom for the molding of medical components.
Smith & Nephew To Pay $22.2M For Greek Bribery
February 6, 2012 2:18 pm | by Marcy Gordon, AP Business Writer | News | CommentsThe British orthopedics maker was accused by the DOJ and SEC of bribing doctors employed by the Greek government for more than a decade to win business.
